Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER

Recurrent Distal Bile Duct Adenocarcinoma

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Recurrent Distal Bile Duct Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Bortezomib
National Cancer Institute (NCI)
Phase 2CCC
Cobimetinib
National Cancer Institute (NCI)
Phase 2CCC
Atezolizumab
National Cancer Institute (NCI)
Phase 2CCC
Durvalumab
University of Southern California
Phase 1CC
Guadecitabine
University of Southern California
Phase 1CC

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:

B-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
49 / 100
View asset →
Advanced Ovarian CarcinomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →